Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: vaccination

Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations

Susan Bernstein  |  July 6, 2021

Hesitancy about COVID-19 vaccination persists nationwide, although it varies among regions and sociodemographic groups.

Filed under:Conditions Tagged with:COVID-19vaccinationvaccinevaccine hesitancy

ACR Quality of Care Committee Impresses with Its Recent Productivity

Ruth Jessen Hickman, MD  |  June 14, 2021

Over the past 18 months, the ACR’s Quality of Care (QOC) Committee has helped produce an impressive number of resources that will help rheumatologists deliver the best possible care. Working through specific projects supervised under its Criteria, Guideline, Guidance, and Quality Measure subcommittees, the QOC Committee has developed new sets of disease criteria, clinical guidelines,…

Filed under:Clinical Criteria/GuidelinesFrom the CollegeQuality Assurance/Improvement Tagged with:Classification CriteriaCommittee on Quality of Care

Anze Furlan / SHUTTERSTOCK.COM

How Immunosuppression May Affect COVID-19 Vaccine Response

Ruth Jessen Hickman, MD  |  June 13, 2021

Although we can expect to learn much more, preliminary data are now available on the potential safety and effectiveness of COVID-19 vaccines in rheumatology patients. The picture is likely to be nuanced, with not all types of immuno­suppressive treatments having identical impacts on vaccine response. Rheumatologists should use caution in interpreting early reports, while continuing…

Filed under:Conditions Tagged with:COVID-19immunosuppressionvaccination

ACR Advocacy: 2021 Midyear Update

Elizabeth (Blair) Solow, MD  |  June 13, 2021

Beginning in the late 1800s, Eliza Ruhamah Scidmore, U.S. diplomat and writer, spent 24 years advocating for sakura, or Japanese cherry trees, to be planted in Washington, D.C. After unsuccessfully petitioning every U.S. Army Superintendent of Public Buildings and Grounds for over two decades, she wrote a letter to First Lady Helen Herron Taft about…

Filed under:From the CollegeLegislation & AdvocacyWorkforce Tagged with:ACR Government Affairs CommitteeCenters for Medicare & Medicaid Services (CMS)telehealth

A Unified Advocacy Voice for Rheumatology

David R. Karp, MD, PhD, & Christine Stamatos, DNP, ANP-C  |  June 13, 2021

One thing that became clear very quickly this past year was that the COVID-19 pandemic would change the way we deliver care to patients. What has not changed amid an evolving healthcare landscape is our driving focus to ensure our patients’ access to rheumatology care and the availability of state-of-the-art treatments. We know you share…

Filed under:Legislation & AdvocacyPresident's Perspective Tagged with:COVID-19RheumPACSafe Step Act

Persistence Pays Off: 2021 Midyear Advocacy Update

Elizabeth (Blair) Solow, MD  |  May 21, 2021

Sequestration, workforce issues and step therapy reform are just some of the areas in which the ACR’s activities, via the Government Affairs Committee and member action, have made a positive difference for rheumatology practitioners.

Filed under:Legislation & Advocacy Tagged with:Blair SolowGovernment Affairs Committee (GAC)

Yellow Card for the Yellow Card

Philip Seo, MD, MHS  |  May 13, 2021

Independence Day. I can’t wait. Generally, it’s not a holiday that carries a lot of meaning for me. Having grown up in New York and Boston, the smaller firework displays that take place in Baltimore fail to impress. Also, as a program director, the holiday falls in the middle of the new fellows’ first week…

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:COVID-19vaccinationvaccine passport

More Info on the J&J COVID-19 Vaccine Thrombosis Scare

Mary Choy, PharmD, BCGP, FASHP  |  May 13, 2021

More than 7 million doses of the Johnson & Johnson single-dose vaccine have been administered in the U.S.1 On Apr. 23, the Centers for Disease Control & Prevention (CDC) and the U.S. Food & Drug Administration (FDA) recommended lifting the recommended pause on Johnson & Johnson COVID-19 vaccine use following a thorough safety review. 2…

Filed under:Drug Updates Tagged with:COVID-19vaccinationvaccine

4 ARP Members Talk About Their Roads to Advocacy & Why It Matters

From ARP Representatives to the ACR Government Affairs Committee  |  May 13, 2021

The Budget Control Act of 2011 cut Medicare physician payments by 2% across the board. The Coronavirus Aid, Relief, and Economic Security (CARES) Act, signed into law in 2020, suspended this sequester (i.e., a cut in government spending) between May 1 and Dec. 31, 2020. In the Consolidated Appropriations Act, signed into law in December…

Filed under:Interprofessional PerspectiveLegislation & Advocacy Tagged with:Association of Rheumatology Professionals (ARP)

What the ARP & the College Are Doing For You

Christine Stamatos, DNP, ANP-C  |  April 17, 2021

As we emerge from the grips of a global pandemic, we are taking this opportunity to pause and reflect on the ARP and what our division brings to the care of our patients. I found the words of Amanda Gordon’s inaugural reading of her poem, “The Hill We Climb,” inspirational and instructive for our past,…

Filed under:Clinical Criteria/GuidelinesEducation & TrainingInterprofessional PerspectiveProfessional TopicsResearch Rheum Tagged with:ACR on Air podcastAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)COVID-19Rheumatology Research FoundationVirtual Rheumatology Learning Collaborative (ViRL)

  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 24
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences